| 1 | [SID47193736] | Active | EC50 | 0.657 | Fluorescence Cell-Based Retest of C. albicans Growth in the Presence of Fluconazole [AID2467, Type: confirmatory] | |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 47193736 | | CID | 992 | | Outcome | Active | | EC50 | 0.657 [uM] | | BioAssay | Fluorescence Cell-Based Retest of C. albicans Growth in the Presence of Fluconazole | | AID | 2467 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 2 | [SID47193736] | Active | AbsAC1000_uM | 2.888 | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity [AID540271, Type: confirmatory] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 47193736 | | CID | 992 | | Outcome | Active | | AbsAC1000_uM | 2.888 [uM] | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity | | AID | 540271 | | BioAssay type | confirmatory | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 3 | [SID47193736] | Active | Potency | 8.1995 | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. [AID624296, Type: confirmatory] | GMNN gene product [Homo sapiens] [gi:7705682] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 47193736 | | CID | 992 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. | | AID | 624296 | | BioAssay type | confirmatory | | Target | GMNN gene product [Homo sapiens] [gi:7705682] | | PubMed | | | Data Table |  |
|
| 4 | [SID26747311] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26747311 | | CID | 992 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 5 | [SID26747311] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26747311 | | CID | 992 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 6 | [SID26747311] | Active | Potency | 14.1254 | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) [AID894, Type: confirmatory] | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26747311 | | CID | 992 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase) | | AID | 894 | | BioAssay type | confirmatory | | Target | 15-hydroxyprostaglandin dehydrogenase [NAD+] isoform 1 [Homo sapiens] [gi:31542939] | | PubMed | | | Data Table |  |
|
| 7 | [SID17389771] | Active | Potency | 16.7855 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 16.7855 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 8 | [SID17389771] | Active | Potency | 16.7855 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 16.7855 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 9 | [SID17389771] | Active | Potency | 16.7855 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 16.7855 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 10 | [SID17389771] | Active | Potency | 16.7855 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 16.7855 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 11 | [SID17389771] | Active | Potency | 16.7855 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 16.7855 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 12 | [SID17389771] | Active | Potency | 17.7828 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 13 | [SID17389771] | Active | Potency | 17.7828 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 17.7828 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 14 | [SID17389771] | Active | Potency | 19.9526 | qHTS Assay for Anthrax Lethal Toxin Internalization [AID912, Type: confirmatory] | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for Anthrax Lethal Toxin Internalization | | AID | 912 | | BioAssay type | confirmatory | | Target | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] | | PubMed | | | Data Table |  |
|
| 15 | [SID47193736] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 47193736 | | CID | 992 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 16 | [SID47193736] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 47193736 | | CID | 992 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 17 | [SID47193736] | Active | Potency | 20.5962 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 47193736 | | CID | 992 | | Outcome | Active | | Potency | 20.5962 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 18 | [SID17389771] | Active | Potency | 22.3872 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 19 | [SID17389771] | Active | Potency | 22.3872 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 20 | [SID17389771] | Active | Potency | 22.3872 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 21 | [SID17389771] | Active | Potency | 22.3872 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 22.3872 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 22 | [SID26747311] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26747311 | | CID | 992 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 23 | [SID26747311] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26747311 | | CID | 992 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 24 | [SID26747311] | Active | Potency | 23.1093 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | TDP1 protein [Homo sapiens] [gi:79154014] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26747311 | | CID | 992 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | TDP1 protein [Homo sapiens] [gi:79154014] | | PubMed | | | Data Table |  |
|
| 25 | [SID47193736] | Active | Potency | 23.1093 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 47193736 | | CID | 992 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 26 | [SID47193736] | Active | Potency | 23.1093 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 47193736 | | CID | 992 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 27 | [SID47193736] | Active | Potency | 23.1093 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 47193736 | | CID | 992 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 28 | [SID47193736] | Active | Potency | 23.1093 | Nrf2 qHTS screen for inhibitors [AID504444, Type: confirmatory] | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 47193736 | | CID | 992 | | Outcome | Active | | Potency | 23.1093 [uM] | | BioAssay | Nrf2 qHTS screen for inhibitors | | AID | 504444 | | BioAssay type | confirmatory | | Target | nuclear factor erythroid 2-related factor 2 isoform 2 [Homo sapiens] [gi:224028257] | | PubMed | | | Data Table |  |
|
| 29 | [SID26752917] | Active | Potency | 24.3365 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26752917 | | CID | 992 | | Outcome | Active | | Potency | 24.3365 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 30 | [SID26752917] | Active | Potency | 24.3365 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26752917 | | CID | 992 | | Outcome | Active | | Potency | 24.3365 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 31 | [SID26752917] | Active | Potency | 24.3365 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26752917 | | CID | 992 | | Outcome | Active | | Potency | 24.3365 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 32 | [SID26752917] | Active | Potency | 24.3365 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26752917 | | CID | 992 | | Outcome | Active | | Potency | 24.3365 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 33 | [SID17389771] | Active | Potency | 25.1189 | qHTS assay for small molecule antagonists of farnesoid X receptor signaling [AID588526, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS assay for small molecule antagonists of farnesoid X receptor signaling | | AID | 588526 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table |  |
|
| 34 | [SID17389771] | Active | Potency | 25.1189 | qHTS assay for small molecule antagonists of farnesoid X receptor signaling [AID588526, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS assay for small molecule antagonists of farnesoid X receptor signaling | | AID | 588526 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table |  |
|
| 35 | [SID17389771] | Active | Potency | 25.1189 | qHTS assay for small molecule antagonists of farnesoid X receptor signaling [AID588526, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS assay for small molecule antagonists of farnesoid X receptor signaling | | AID | 588526 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table |  |
|
| 36 | [SID17389771] | Active | Potency | 25.1189 | qHTS assay for small molecule antagonists of farnesoid X receptor signaling [AID588526, Type: confirmatory] | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS assay for small molecule antagonists of farnesoid X receptor signaling | | AID | 588526 | | BioAssay type | confirmatory | | Target | farnesoid X nuclear receptor [Homo sapiens] [gi:325495553] | | PubMed | | | Data Table |  |
|
| 37 | [SID17389771] | Active | Potency | 26.6032 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 26.6032 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 38 | [SID17389771] | Active | Potency | 26.6032 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 26.6032 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 39 | [SID17389771] | Active | Potency | 26.6032 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 26.6032 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 40 | [SID17389771] | Active | Potency | 26.6032 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 26.6032 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|
| 41 | [SID17389771] | Active | Potency | 31.6228 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 42 | [SID17389771] | Active | Potency | 31.6228 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 43 | [SID17389771] | Active | Potency | 31.6228 | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 [AID938, Type: confirmatory] | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17389771 | | CID | 992 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293 | | AID | 938 | | BioAssay type | confirmatory | | Target | thyroid stimulating hormone receptor [Homo sapiens] [gi:38016895] | | PubMed | | | Data Table |  |
|
| 44 | [SID26752917] | Active | Potency | 39.8107 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26752917 | | CID | 992 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 45 | [SID26752917] | Active | Potency | 39.8107 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26752917 | | CID | 992 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 46 | [SID26752917] | Active | Potency | 39.8107 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26752917 | | CID | 992 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 47 | [SID26752917] | Active | Potency | 39.8107 | qHTS assay for small molecule activators of the p53 signaling pathway [AID651743, Type: confirmatory] | Cellular tumor antigen p53 [gi:269849759] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26752917 | | CID | 992 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS assay for small molecule activators of the p53 signaling pathway | | AID | 651743 | | BioAssay type | confirmatory | | Target | Cellular tumor antigen p53 [gi:269849759] | | PubMed | | | Data Table |  |
|
| 48 | [SID26747311] | Active | Potency | 39.8107 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26747311 | | CID | 992 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 49 | [SID26747311] | Active | Potency | 39.8107 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26747311 | | CID | 992 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|
| 50 | [SID26747311] | Active | Potency | 39.8107 | Inhibitors of the vitamin D receptor (VDR): qHTS [AID504847, Type: confirmatory] | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26747311 | | CID | 992 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | Inhibitors of the vitamin D receptor (VDR): qHTS | | AID | 504847 | | BioAssay type | confirmatory | | Target | vitamin D3 receptor isoform VDRA [Homo sapiens] [gi:63054845] | | PubMed | | | Data Table |  |
|